Department of Rehabilitation and Sport Sciences, Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, South West, UK.
Department of Sport and Exercise Sciences, Faculty of Social Sciences and Health, Durham University, Durham, North East, UK.
Health Expect. 2024 Oct;27(5):e70079. doi: 10.1111/hex.70079.
We investigated whether a novel 8-week personalised health behaviour support programme, focusing on the stability of symptoms and strategies to improve activities of daily living, was feasible and acceptable in adults with post-COVID syndrome.
In this randomised, controlled, pilot feasibility trial, 32 adults with post-COVID syndrome (continued symptoms for ≥ 12 weeks) were randomised 1:1 to receive personalised health behaviour support (self-reported physical activity and symptom diaries, plus seven one-to-one remotely delivered personalised self-management support sessions), once weekly for 8-weeks, or usual care (referral to online 'your COVID-19 recovery' programme). The primary outcome was the feasibility of recruiting and randomising adults with post-COVID syndrome. The secondary outcomes were to assess the acceptability and safety of the intervention and various outcome measures.
Of the 48 adults who expressed interest in the study, 32 (67%) were eligible and completed the baseline assessment. All 32 adults were willing to be randomised to either the personalised health behaviour support programme (n = 17) or usual care (n = 15) and 27 (age: 45 ± 12 years) adults completed follow-up at 9 weeks. The intervention was deemed feasible, with high adherence (92% and 94% completion rates for the physical activity and symptom diaries, respectively) and excellent acceptability rates (94% 'liked the intervention a lot'). The intervention was deemed safe, with no symptom exacerbations reported.
An 8-week personalised health behaviour support programme was feasible for adults with post-COVID syndrome, with good adherence and acceptability rates. Early pilot data from this small sample also suggests meaningful improvements in physical activity, fatigue and respiratory symptoms.
People living with post-COVID syndrome were involved from the outset with the study design, review of study documentation and interpretation of the data following completion. Furthermore, several participants have supported the local dissemination of findings following the completion of the study.
我们研究了一种新的 8 周个性化健康行为支持方案,该方案侧重于症状的稳定性和改善日常生活活动的策略,是否适用于患有新冠后综合征的成年人,以及是否可行和可接受。
在这项随机、对照、初步可行性试验中,32 名新冠后综合征患者(症状持续≥12 周)按 1:1 比例随机分为接受个性化健康行为支持(自我报告的体力活动和症状日记,外加 7 次一对一远程提供的个性化自我管理支持会议)组,每周 1 次,持续 8 周,或接受常规护理(转介至在线“你的新冠康复”计划)。主要结局是评估招募和随机分配新冠后综合征成年患者的可行性。次要结局是评估干预措施的可接受性和安全性,以及各种结局测量。
在表示有兴趣参与研究的 48 名成年人中,有 32 名(67%)符合条件并完成了基线评估。所有 32 名成年人都愿意随机分配至个性化健康行为支持方案组(n=17)或常规护理组(n=15),其中 27 名(年龄:45±12 岁)成年人在 9 周时完成了随访。该干预措施被认为是可行的,具有高依从性(体力活动和症状日记的完成率分别为 92%和 94%)和极好的可接受性(94%的人“非常喜欢该干预措施”)。该干预措施被认为是安全的,没有报告症状恶化。
8 周个性化健康行为支持方案对新冠后综合征成年人是可行的,具有较高的依从性和可接受性。从小样本的早期初步数据来看,该方案还可以显著改善体力活动、疲劳和呼吸症状。
从研究设计开始,患有新冠后综合征的患者就参与其中,他们参与了研究文件的审查和数据解释。此外,在研究完成后,一些参与者还支持了研究结果在当地的传播。